Dear Doctor:
Welcome to Doctor's Guide Weekly Cardiology edition, the e-newsletter designed to help you quickly and easily stay abreast of the latest Cardiology news! Doctor's Guide Weekly delivers the top news most read by your colleagues including:
The most relevant clinical papers from 2,000+ peer-reviewed journals
Timely professional medical news alerts
Key scientific developments from over 120 medical conferences annually Please accept this free subscription with our compliments. We are confident that you will find Doctor's Guide Weekly to be an invaluable tool in "Keeping you up to date...Always".
Best regards, Doctor's Guide Weekly Publishing Team
TOP READ in the past 7 daysNew oral anticoagulants in atrial fibrillationThis paper reviews the mechanism of platelet inhibition and vitamin K antagonism in the prevention of stroke among patients with atrial fibrillation, the possible adverse pharmacological effects of these agents, the targets for novel anticoagulants, and the new agents in various stages of clinical development...Full Story
Most read Cardiology news in the past 7 daysPapers and articles, pertaining to Cardiology, most read by your colleagues in the past 7 days
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy (Atherosclerosis)
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial* (Crit Care Med)
Curing atrial fibrillation: Two decades of progress (J Interv Card Electrophysiol)
Management of ST-segment elevation myocardial infarction in EDs (Am J Emerg Med)
Less increase of BNP and NT-proBNP levels in obese patient with decompensated heart failure Interpretation of natriuretic peptides in obesity (Int J Cardiol)
Endovenous 980-nm laser treatment of saphenous veins in a series of 500 patients (J Vasc Surg)
From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy (J Hypertens)
Paraoxonase (PON1) is associated with familial combined hyperlipidemia (Atherosclerosis)
Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials (Clin Ther)
Long-term survival in patients older than 80 years hospitalised for heart failure. A 5-year prospective study (Eur J Heart Failure)
No comments:
Post a Comment